Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Merck KGaA
  6. News
  7. Summary
    MRK   DE0006599905

MERCK KGAA

(MRK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

MERCK KGAA : Goldman Sachs maintains a Sell rating

05/17/2021 | 07:01am EDT

In his latest research note, analyst Krishna Chaitanya Arikatla confirms his negative recommendation. The broker Goldman Sachs is keeping its Sell rating. The target price differs slightly and is now set at EUR 112 versus EUR 110.


© MarketScreener with dpa-AFX Analyser 2021
All news about MERCK KGAA
06/15MERCK KGAA  : Berenberg gives a Neutral rating
MD
06/10Volkswagen, Nine Others Set Up Quantum Technology & Application Consortium
MT
06/10MERCK  : Obtains Halal Certifications For All Cosmetics Products
MT
06/10PRESS RELEASE : ObsEva Presents PROLONG Phase 2a Proof-of-Concept Data on Ebopip..
DJ
06/09MERCK KGAA  : UBS reaffirms its Neutral rating
MD
06/02Germany to build up reserve vaccine capacity to fight future pandemics
RE
06/02PRESS RELEASE : CureVac Appoints Klaus Edvardsen as Chief Development Officer
DJ
06/01Immutep, Merck KGaA Expand Collaboration in Solid Tumors
MT
06/01Merck KgaA Partners With Immutep For Trial In Solid Tumor Patients
MT
06/01Immutep in Collaboration, Supply Agreement With Merck KGaA
DJ
More news
Financials
Sales 2021 18 882 M 22 891 M 22 891 M
Net income 2021 2 551 M 3 093 M 3 093 M
Net Debt 2021 8 694 M 10 541 M 10 541 M
P/E ratio 2021 25,9x
Yield 2021 0,99%
Capitalization 66 847 M 81 066 M 81 040 M
EV / Sales 2021 4,00x
EV / Sales 2022 3,70x
Nbr of Employees 57 850
Free-Float 29,7%
Chart MERCK KGAA
Duration : Period :
Merck KGaA Technical Analysis Chart | MRK | DE0006599905 | MarketScreener
Technical analysis trends MERCK KGAA
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 150,97 €
Last Close Price 153,75 €
Spread / Highest target 20,3%
Spread / Average Target -1,81%
Spread / Lowest Target -27,2%
EPS Revisions
Managers and Directors
NameTitle
Belén Garijo López Chairman-Executive Board & CEO
Marcus Kuhnert Chief Financial Officer
Wolfgang Heinz Büchele Chairman-Supervisory Board
Nilesh Kumar Senior Investment Director
Christian Raabe Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
MERCK KGAA9.55%81 066
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD49.29%37 612
KYOWA KIRIN CO., LTD.34.15%18 418
SK BIOPHARMACEUTICALS CO., LTD.-29.59%8 333
BETTA PHARMACEUTICALS CO., LTD.-3.53%6 681
YUHAN CORPORATION-14.38%3 758